Sales decline 1.54% to Rs 330.20 crore
Net profit of Marksans Pharma rose 86.01% to Rs 79.50 crore in the quarter ended March 2021 as against Rs 42.74 crore during the previous quarter ended March 2020. Sales declined 1.54% to Rs 330.20 crore in the quarter ended March 2021 as against Rs 335.35 crore during the previous quarter ended March 2020.For the full year,net profit rose 97.55% to Rs 238.54 crore in the year ended March 2021 as against Rs 120.75 crore during the previous year ended March 2020. Sales rose 21.33% to Rs 1376.18 crore in the year ended March 2021 as against Rs 1134.21 crore during the previous year ended March 2020.
ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales330.20335.35 -2 1376.181134.21 21 OPM %28.8920.63 -24.6816.95 - PBDT98.5667.19 47 338.32183.84 84 PBT97.2257.56 69 302.16157.17 92 NP79.5042.74 86 238.54120.75 98
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
